CF
NTLA icon

CNA Financial’s Intellia Therapeutics NTLA Stock Holding History

CNA Financial’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,510
Closed -$364K – 136
2022
Q3 		$364K Sell
6,510
-2,090
-24% -$130K 0.14% 139
2022
Q2 		$445K Sell
8,600
-390
-4% -$19.8K 0.16% 137
2022
Q1 		$653K Buy
8,990
+1,080
+14% +$91.5K 0.2% 130
2021
Q4 		$935K Buy
7,910
+880
+13% +$110K 0.24% 111
2021
Q3 		$943K Buy
7,030
+280
+4% +$42.4K 0.26% 116
2021
Q2 		$1.09M Sell
6,750
-3,830
-36% -$298K 0.31% 99
2021
Q1 		$849K Buy
+10,580
New +$710K 0.26% 116

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

CNA Financial's NTLA Position: Q4 2022 in Review

CNA Financial sold out of Intellia Therapeutics (NTLA) in Q4 2022, closing a stake of 6,510 shares — an estimated $364K sold.

CNA Financial first reported a position in NTLA in Q1 2021 and held it in 7 quarters. The position peaked at $1.09M in Q2 2021. 303 funds tracked by Wall St. Rank hold NTLA as of Q4 2022.

  • CNA Financial reported no remaining Intellia Therapeutics position as of Q4 2022 after selling out during the quarter.
  • CNA Financial sold 6,510 Intellia Therapeutics shares in Q4 2022, an estimated $364K.
  • CNA Financial first reported a position in Intellia Therapeutics in Q1 2021 and held it in 7 quarters.
  • CNA Financial's Intellia Therapeutics position peaked at $1.09M in Q2 2021.
  • 303 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.